Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for Diabetic Retinopathy with Dyslipidemia
NCT04885153Completed
- Sponsor
- Universitas Indonesia
- Start
- Nov 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of fenofibrate in diabetic retinopathy (DR) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Central Macular Thickness at 3 months, Macular Volume at 3 months and 3 more. Started Nov 2016; status: completed.
02
Drugs
fenofibrate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT04885153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885153.